Study of CHS-388 (Formerly Known as SRF388) in Patients With Advanced Solid Tumors
Coherus Oncology, Inc.
Coherus Oncology, Inc.
UNC Lineberger Comprehensive Cancer Center
MacroGenics
National Institutes of Health Clinical Center (CC)
Washington University School of Medicine
Novita Pharmaceuticals, Inc.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
DxTerity Diagnostics
VA Office of Research and Development
Xencor, Inc.
Celldex Therapeutics
Klus Pharma Inc.
Xencor, Inc.
Quadriga Biosciences, Inc.
Xencor, Inc.
Exact Sciences Corporation
Pfizer
Novartis
Eli Lilly and Company
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Alliance for Clinical Trials in Oncology
Zhujiang Hospital
University of Zurich
University of Chicago
Stanford University
University of Kansas Medical Center
Roswell Park Cancer Institute
Santa Maria Biotherapeutics
M.D. Anderson Cancer Center
Children's Oncology Group
Fox Chase Cancer Center
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
Uppsala University Hospital
Duke University
AEterna Zentaris
University of Chicago
National Cancer Institute (NCI)
Duke University
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)